# OnCo record nct07773363 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07773363/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07773363", "NCT07773363" ;
  schema:name "Retlirafusp Alfa Plus Apatinib and Chemotherapy as Second-Line Treatment for Pancreatic Cancer"@en ;
  schema:description "A phase 2 trial of retlirafusp alfa and rivoceranib (apatinib) in pancreatic cancer, run by Tang-Du Hospital, not yet recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07773363/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07773363> ;
  onco:status "planned" ;
  onco:tag "ctgov-ingest", "pancreatic-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/locally-advanced-pdac/>, <https://onco.cc/cancers/metastatic-pdac/> ;
  onco:drugs <https://onco.cc/drugs/retlirafusp-alfa/>, <https://onco.cc/drugs/rivoceranib/> .